Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review voucher
Pharma
FDA signs off on Valneva's chikungunya vaccine Ixchiq
FDA has approved the world’s first chikungunya vaccine, giving a nod to Valneva’s Ixchiq. The accelerated approval is subject to a confirmatory study.
Kevin Dunleavy
Nov 10, 2023 9:55am
Krystal's topical gene therapy Vyjuvek gains steam: analyst
Nov 6, 2023 3:14pm
Subcutaneous Vyvgart helps Argenx treat a 'broader population'
Nov 1, 2023 9:35am
Bluebird inks deal to sell lovo-cel FDA voucher for $103M
Oct 30, 2023 2:05pm
Sarepta pawns off PRV for $102M to unidentified buyer
Jul 6, 2023 8:10am
Astellas' menopause drug, after delay, crosses FDA finish line
May 12, 2023 4:52pm